Monday, February 21, 2022
The Translational Cardiovascular Research Center — headed by associate dean of Research Christopher Glembotski, PhD — provides state-of-the-art treatment for heart patients in Phoenix, including those with atrial fibrillation (AFib).
AFib is the most common form of treated heart arrhythmia — an irregular heart rhythm, which can lead to blood clots in the heart or stroke.
Through their patient-specific precision medicine treatment, they are helping to identify which medications can best help patients suffering from this condition.